Allan Shaw reports a stock award at CalciMedica
By AlphaYouPublished Form 4
Shaw Allan
Reporting filer
Allan Shaw reports a stock award, not an open-market purchase or sale, in CalciMedica, Inc.. Form 4 filed Oct 5, 2026 lists 1 entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) (derivative) | Shaw Allan | 2026-10-01 | A | Grant or award | 20000 | 0 | 20,000 | 4 days | Filed terms
|
Director Stock Option (Right to Buy) (derivative)
- Owner
- Shaw Allan
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 20000
- Price
- 0
- Following holdings
- 20,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Director Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.64
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 20000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-09-30
- underlying Security Title: Common Stock
- underlying Security Shares: 20000
- shares Owned Following Transaction: 20000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Shaw Allan: Director.
- F1: Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc.
Original sources
Prepared automatically from public filing data. Report a correction.